Drug Profile
SSR 241586
Alternative Names: SSR241586Latest Information Update: 17 Mar 2009
Price :
$50
*
At a glance
- Originator sanofi-aventis
- Class Antidepressants; Antipsychotics; Anxiolytics; Irritable bowel syndrome therapies
- Mechanism of Action Neurokinin 2 receptor antagonists; Neurokinin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Irritable bowel syndrome; Major depressive disorder; Schizophrenia
Most Recent Events
- 17 Sep 2007 Phase-I clinical trials in Anxiety disorders in France (unspecified route)
- 17 Sep 2007 Phase-I clinical trials in Depression in France (unspecified route)
- 17 Sep 2007 Phase-I clinical trials in Irritable bowel syndrome in France (unspecified route)